Jasper Ridge Partners’s Epizyme, Inc EPZM Stock Holding History

Jasper Ridge Partners’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,619	Closed	-$32K	–	154
2022 Q2	$32K	Hold	21,619	–	–	﹤0.01%	144
2022 Q1	$25K	Hold	21,619	–	–	﹤0.01%	151
2021 Q4	$54K	Hold	21,619	–	–	﹤0.01%	148
2021 Q3	$111K	Hold	21,619	–	–	﹤0.01%	142
2021 Q2	$180K	Buy	21,619 +2,227	+11%	+$18.8K	0.01%	129
2021 Q1	$169K	Hold	19,392	–	–	0.01%	114
2020 Q4	$211K	Hold	19,392	–	–	0.01%	108
2020 Q3	$231K	Hold	19,392	–	–	0.01%	106
2020 Q2	$311K	Buy	+19,392	New	+$339K	0.02%	95
2015 Q2	–	Sell	-16,108	Closed	-$303K	–	95
2015 Q1	$303K	Hold	16,108	–	–	0.02%	77
2014 Q4	$304K	Hold	16,108	–	–	0.02%	72
2014 Q3	$437K	Buy	+16,108	New	+$501K	0.03%	76

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Jasper Ridge Partners's EPZM Position: Q3 2022 in Review

Jasper Ridge Partners sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 21,619 shares — an estimated $32K sold.

Jasper Ridge Partners first reported a position in EPZM in Q3 2014 and held it in 12 quarters. The position peaked at $437K in Q3 2014. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Jasper Ridge Partners reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Jasper Ridge Partners sold 21,619 Epizyme, Inc shares in Q3 2022, an estimated $32K.
Jasper Ridge Partners first reported a position in Epizyme, Inc in Q3 2014 and held it in 12 quarters.
Jasper Ridge Partners's Epizyme, Inc position peaked at $437K in Q3 2014.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Jasper Ridge Partners's 13F filing for Q3 2022, filed 14 Nov 2022.